Hyacinthe A Johnson-Ansah (Hyacinthe Johnson-Ansah)

Years Active: 2019-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Henry, Claire Bracquemart, Dina Naguib, Sylvain Chantepie, Stephane Cheze, Hyacinthe A Johnson-Ansah
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question. British journal of haematology 195 (3) (2021)
Franck Emmanuel Nicolini, Stephanie Dulucq, Lisa Boureau, Pascale Cony-Makhoul, Aude Charbonnier, Martine Escoffre-Barbe, Françoise Rigal-Huguet, Valérie Coiteux, Bruno Varet, Viviane Dubruille, Pascal Lenain, Philippe Rousselot, Delphine Rea, Agnès Guerci-Bresler, Laurence Legros, Jixing Liu, Martine Gardembas, Jean-Christophe Ianotto, Pascal Turlure, Hyacinthe A Johnson-Ansah, Juliana Martiniuc, Henry Jardel, Bertrand Joly, Patricia Zunic, Tawfiq Henni, Bruno Villemagne, Marc G Berger, Emilie Cayssials, François Guilhot, Fabrice Larosa, Joëlle Guilhot, Gabriel Etienne, François-Xavier Mahon
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (22) (2019)

Hyacinthe A Johnson-Ansah.css-eqlu8i{font-size:small;padding-left:4px;} (Hyacinthe Johnson-Ansah)